2397 — DNA Chip Research Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for DNA Chip Research, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	658	302	621	489	275
Net Total Accounts Receivable
Net Total Receivables	135	166	150	173	206
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	810	532	825	710	525
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	14.9	24.4	17.4	2.44	114
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	865	743	1,021	890	871
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	89	82.7	81.7	99.3	121
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	95.6	90.1	90.4	110	160
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	769	653	931	781	711
Total Liabilities & Shareholders' Equity	865	743	1,021	890	871
Total Common Shares Outstanding